Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of California, Los Angeles
Study ID
NCT05518305
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
30 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Medical Imaging — DIAGNOSTIC_TEST
    magnetic resonance imaging

Study Details

An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.

Key Dates

Start date
Sep 30, 2022
Status verified
Jun 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
250 participants (estimated)

Arms

  • Arm: All
    Blood sampling and an MRI will be conducted alongside standard stroke cognitive tests upon enrollment. A follow-up three-month visit will check for adverse events and a follow-up cognitive stroke test. At 12 months, an MRI will be conducted alongside a cognitive test.

Primary Outcome Measure

Determine the impact of platelet FcγRIIa expression on 1-year risk of recurrent stroke in ICAD. [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Ronald Reagan UCLA Medical CenterLos AngelesCalifornia90095
David Liebeskind, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By condition
Stroke
By specialty
NeurologyBrain disorders
By research site
Ronald Reagan UCLA Medical Center· Los Angeles, CA

Related Studies